The Chiradzulu programme is one of MSF's largest. MSF currently provides HAART to more than 13,000 patients in 56 projects spread across 25 countries. These programmes provide a continuum of care, including prevention efforts (health education, prevention of mother-to-child transmission of HIV), voluntary counselling and testing, prevention and treatment of opportunistic infections, HAART and nutritional and psychosocial support. Although the Chiradzulu project is still evolving, and treatment systems and point of care continue to be modified, the project has already shown that when treatment is adapted to local conditions and is supported by human and financial resources, rural health systems can effectively provide comprehensive HIV/AIDS care
This report calls on international donors to join with African countries in implemeting World Health Organization (WHO) guidelines on the treatment of malaria. WHO recommends that African countries facing resistance to classical antimalarials introduce drug combinations containing artemisinin derivatives - artemisinin-based combination therapy (ACT). This report defines the malaria problem, looks at what works in malaria treatment and outlines what needs to be done to make ACT work in reality
Documents MSF's experience of purchasing anti-retroviral drugs in ten low and middle income countries. The report looks at ARV selection, pricing and procurement issues. It highlights five issues: sources (quality), registration, prices, patents, and the continous availability of medicines